“The Reply to the Letter to the Editor Regarding: ‘The Autologous CaTeVac Dendritic Cell Vaccine in Patients With Melanoma: Final Results of the DENDRON-01 Study’”. Voprosy Onkologii, vol. 72, no. 1, Mar. 2026, p. OF-2568, https://doi.org/10.37469/0507-3758-2026-72-1-OF-2568.